SMTL ID : 3kc3.5 (4 other biounits)

MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

homo-12-mer

Ligands

11 x MK2: N~4~-[7-(1-benzofuran-2-yl)-1H-indazol-5-yl]pyrimidine-2,4-diamine(Non-covalent)

MK2.1: 14 residues within 4Å: Chain A: L.30, G.33, V.38, A.51, K.53, H.68, M.98, E.99, C.100, L.101, D.102, L.153, T.166, D.167 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:V.38, A:V.38, A:D.102, A:L.153, A:L.153 Hydrogen bonds: A:H.68, A:L.101, A:L.101, A:T.166, A:D.167 Salt bridges: A:D.167 MK2.2: 13 residues within 4Å: Chain B: L.30, V.38, A.51, K.53, M.98, E.99, C.100, L.101, D.102, G.104, L.153, T.166, D.167 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:L.30, B:V.38, B:L.153 Hydrogen bonds: B:L.101, B:L.101, B:T.166, B:T.166, B:D.167 Salt bridges: B:D.167 MK2.3: 14 residues within 4Å: Chain C: L.30, G.33, V.38, A.51, K.53, H.68, M.98, E.99, C.100, L.101, G.104, L.153, T.166, D.167 9 PLIP interactions: 9 interactions with chain C Hydrophobic interactions: C:L.30, C:V.38, C:L.153 Hydrogen bonds: C:L.101, C:L.101, C:T.166, C:T.166, C:D.167 Salt bridges: C:D.167 MK2.4: 14 residues within 4Å: Chain D: L.30, V.38, A.51, K.53, H.68, M.98, E.99, C.100, L.101, D.102, G.104, L.153, T.166, D.167 7 PLIP interactions: 7 interactions with chain D Hydrophobic interactions: D:V.38, D:L.153 Hydrogen bonds: D:L.101, D:L.101, D:T.166, D:D.167 Salt bridges: D:D.167 MK2.5: 16 residues within 4Å: Chain E: L.30, L.32, V.38, A.51, K.53, H.68, M.98, E.99, C.100, L.101, D.102, G.104, E.105, L.153, T.166, D.167 9 PLIP interactions: 9 interactions with chain E Hydrophobic interactions: E:L.30, E:V.38, E:L.153 Hydrogen bonds: E:L.101, E:L.101, E:T.166, E:T.166, E:D.167 Salt bridges: E:D.167 MK2.6: 13 residues within 4Å: Chain F: L.30, V.38, A.51, K.53, H.68, M.98, E.99, C.100, L.101, D.102, L.153, T.166, D.167 8 PLIP interactions: 8 interactions with chain F Hydrophobic interactions: F:V.38, F:V.38, F:L.153 Hydrogen bonds: F:L.101, F:L.101, F:T.166, F:D.167 Salt bridges: F:D.167 MK2.7: 14 residues within 4Å: Chain H: L.30, V.38, A.51, K.53, H.68, M.98, E.99, C.100, L.101, D.102, G.104, L.153, T.166, D.167 9 PLIP interactions: 9 interactions with chain H Hydrophobic interactions: H:L.30, H:V.38, H:L.153, H:L.153 Hydrogen bonds: H:L.101, H:L.101, H:T.166, H:D.167 Salt bridges: H:D.167 MK2.8: 16 residues within 4Å: Chain I: L.30, G.31, G.33, V.38, A.51, K.53, H.68, M.98, E.99, L.101, D.102, G.104, E.105, L.153, T.166, D.167 9 PLIP interactions: 9 interactions with chain I Hydrophobic interactions: I:V.38, I:V.38, I:L.153 Hydrogen bonds: I:G.31, I:L.101, I:L.101, I:T.166, I:D.167 Salt bridges: I:D.167 MK2.9: 14 residues within 4Å: Chain J: L.30, G.33, V.38, A.51, K.53, H.68, M.98, E.99, L.101, D.102, G.104, L.153, T.166, D.167 7 PLIP interactions: 7 interactions with chain J Hydrophobic interactions: J:V.38, J:L.153 Hydrogen bonds: J:L.101, J:L.101, J:T.166, J:D.167 Salt bridges: J:D.167 MK2.10: 15 residues within 4Å: Chain K: L.30, G.31, G.33, V.38, A.51, K.53, H.68, M.98, E.99, L.101, D.102, G.104, L.153, T.166, D.167 8 PLIP interactions: 8 interactions with chain K Hydrophobic interactions: K:L.30, K:V.38, K:L.153 Hydrogen bonds: K:L.101, K:L.101, K:T.166, K:D.167 Salt bridges: K:D.167 MK2.11: 15 residues within 4Å: Chain L: L.30, G.31, V.38, A.51, K.53, H.68, M.98, E.99, C.100, L.101, D.102, G.104, L.153, T.166, D.167 9 PLIP interactions: 9 interactions with chain L Hydrophobic interactions: L:V.38, L:V.38, L:L.153, L:L.153 Hydrogen bonds: L:K.53, L:L.101, L:L.101, L:D.167 Salt bridges: L:D.167

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Argiriadi, M.A. et al., 2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding mode. Bioorg.Med.Chem.Lett. (2010)

Release Date

2010-01-12

Peptides

MAP kinase-activated protein kinase 2: ABCDEFGHIJKL

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

E
E

F
F

G
G

H
H

I
I

J
J

K
K

L
L

MAP kinase-activated protein kinase 2

Related Entries With Identical Sequence